Education
About Us
Working with TipRanks
Follow Us
Manzo Pharmaceuticals (MNZO)
OTHER OTC:MNZO
| Dec 04 | Dec 03 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | ||
| Gross Profit | $ 20.97K | $ 755.89K |
| Operating Income | $ -3.20M | $ -3.25M |
| EBITDA | $ -2.85M | $ -2.30M |
| Net Income | $ -4.15M | $ -3.95M |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ ― | $ ― |
| Total Assets | $ 1.29M | $ 4.99M |
| Total Debt | $ 6.52M | $ 7.31M |
| Net Debt | $ 6.51M | $ 7.30M |
| Total Liabilities | $ 23.79M | $ 23.46M |
| Stockholders' Equity | $ ― | $ ― |
| Cash Flow | ||
| Free Cash Flow | $ -1.11M | $ -1.59M |
| Operating Cash Flow | $ -1.11M | $ -1.58M |
| Investing Cash Flow | ||
| Financing Cash Flow |
Manzo Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.